← Eichor
Condition: Salivary Gland Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Salivary Gland

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Sy
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT05927688Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
Phase N/A · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06771427Application of Neuro-electrostimulation as a Treatment for Patients With Dry Mouth
NA · 1 location(s) · Universidad Autonoma del Estado de Mexico · NCT07593495A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RE
Phase 2 · 6 location(s) · Lubris Bio Pty Ltd · NCT07118241Submandibular Gland Stem Cell Transplantation
Phase 1 · 1 location(s) · University Medical Center Groningen · NCT04593589Ultra-High Frequency Ultrasonography in Sjögren's Syndrome
NA · 1 location(s) · University of Pisa · NCT06338735An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
Phase 2 · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT07281456Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
Phase 2 · 1 location(s) · Heidelberg University · NCT04214366Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease
NA · 1 location(s) · Universidade da Coruña · NCT07588191Belimumab After Rituximab in Resistant Primary Juvenile SS
Phase 4 · 1 location(s) · Peking Union Medical College Hospital · NCT06410833Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Phase 2 · 13 location(s) · Dana-Farber Cancer Institute · NCT04620187A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06805617Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3 · 28 location(s) · Vor Biopharma · NCT07404865Local Vibration for Drooling in Children With Cerebral Palsy
NA · 1 location(s) · Bitlis Eren University · NCT07626424A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Phase 1 · 19 location(s) · GlaxoSmithKline · NCT07371468Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06428188Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
Phase 1/Phase 2 · 4 location(s) · RiboX Therapeutics Ltd. · NCT06714253Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye
Phase 1 · 1 location(s) · Iran University of Medical Sciences · NCT06543667The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
Phase 4 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04981145Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT06392711Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade
Phase 2 · 1 location(s) · Myung-Ju Ahn · NCT05727410The Pathogenesis and Natural History of Sjogren's Disease
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT01425892A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Phase 3 · 174 location(s) · Amgen · NCT06747949Immune Biomarker Study for Salivary Gland Carcinoma
Phase N/A · 2 location(s) · University of Erlangen-Nürnberg Medical School · NCT06047236Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT
NA · 1 location(s) · Tzu Chi University · NCT07711626Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation
NA · 1 location(s) · Chinese University of Hong Kong · NCT05296109Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis.
Phase N/A · 14 location(s) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT06630715
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.